Use your browser's back button to choose another title or click here for a New Search.

How to Get the Presentation

 Open slides (ppt)


Bookmark and Share

Never HIV Tested: Results of Screening Data from 12 Drug Treatment Programs in the CTN 0032 HIV Rapid Testing and Counseling Study.

Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.

Lisa R. Metsch, PhD (University of Miami Miller School of Medicine, FL Node), Raul N. Mandler, MD (Center for the Clinical Trials Network (CCTN), NIDA), Daniel J. Feaster, PhD (University of Miami Miller School of Medicine, FL Node), Lauren K. Gooden, MPH (University of Miami Miller School of Medicine, FL Node), Susan Tross, PhD (New York State Psychiatric Institute, LI Node), Louise F. Haynes, MSW (Lexington/Richland Alcohol and Drug Abuse Council, SC Node), Antoine B. Douaihy, MD (Western Psychiatric Institute and Clinic, AT Node), Moupali Das, MD, MPH (San Francisco Department of Public Health, CA/AZ Node), Tiffany L. Kyle, PhD (The Center for Drug-Free Living, Inc., FL Node), P. Todd Korthuis, MD, MPH (Oregon Health & Science University, OR/HI Node), Robert P. Schwartz, MD (Friends Research Institute, Inc., MA Node), Sarah J. Erickson, PhD (Center on Alcoholism, Substance Abuse, and Addictions (CASAA), UNM, SW Node), Ned Snead (Chesterfield Community Services Board, MA Node), James L. Sorensen, PhD (San Francisco General Hospital, UCSF, CA/AZ Node), Grant N. Colfax, MD (San Francisco Department of Public Health, CA/AZ Node).

The Centers for Disease Control and Prevention recommends persons between the ages of 13 and 64 be HIV tested. Drug users are at higher risk for HIV infection compared with the general population, but little is known about the proportion of drug treatment patients that have never been tested for HIV infection. This ancillary study used data from protocol CTN-0032 ("HIV Rapid Testing and Counseling") to investigate past HIV testing histories for over 2400 individuals 18 years and older in 12 community-based drug treatment programs throughout the U.S. Multivariable analysis suggested that African American patients (vs. white patients) were less likely to have never tested for HIV, after controlling for Hispanic ethnicity, gender, age, and injection drug use status. Similarly, injectors (vs. non-injectors) and persons older than 30 were more likely to have been tested for HIV. There was an interaction between race/ethnicity and gender with Hispanic males, non-Hispanic males, and Hispanic females (vs. white females) being more likely to have never been tested for HIV. Results suggest that strategies are needed to improve the uptake of HIV testing for persons in drug abuse treatment. (Presentation, PPT, English, 2010)

Keywords: African Americans | Community health services | CTN platform/ancillary study | Gender differences | Hispanics and Latinos | HIV/AIDS | Minority groups | College on Problems of Drug Dependence (CPDD) annual meeting, 2010

Document No: 500

Submitted by Lisa Metsch, PhD, FL Node, 6/29/2010



Colfax, Grant N. mail
Das, Moupali mail
Douaihy, Antoine B. mail
Erickson, Sarah J. mail
Feaster, Daniel J. mail
Gooden, Lauren K. mail
Haynes, Louise F. mail
Korthuis, P. Todd mail
Kyle, Tiffany L. mail
Mandler, Raul mail
Metsch, Lisa R. mail
Schwartz, Robert P. mail
Snead, Ned mail
Sorensen, James L. mail
Tross, Susan mail
NIDA-CTN-0032 www
Florda Node Alliance search www
Appalachian Tri-State search www
Mid-Atlantic search www
New England Consortium (formerly New England) search www
Ohio Valley search www
Southern Consortium search www
Southwest search www
Western States (formerly California/Arizona and Oregon/Hawaii) search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 6/2010 --